NCT02881125View on ClinicalTrials.gov

Paclitaxel and Nortriptyline Hydrochloride in Treating Patients With Relapsed Small Cell Carcinoma

PHASE1CompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

November 3, 2016

Primary Completion Date

January 1, 2018

Study Completion Date

November 30, 2019

Conditions
Small Cell Carcinoma
Interventions
DRUG

Nortriptyline Hydrochloride

Given PO

DRUG

Paclitaxel

Given IV

Trial Locations (1)

98109

Fred Hutch/University of Washington Cancer Consortium, Seattle

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Washington

OTHER

NCT02881125 - Paclitaxel and Nortriptyline Hydrochloride in Treating Patients With Relapsed Small Cell Carcinoma | Biotech Hunter | Biotech Hunter